Popular
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CEProgress in Breast Cancer Care: Translating SABCS Data Into Practice
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
MinuteCE®Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
Double-Class Refractory CLL in Community Practice: Current and Future Management
CME/CEDouble-Class Refractory CLL in Community Practice: Current and Future Management
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CENavigating Treatment Sequencing After Frontline Treatment Failure in CLL
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
MinuteCE®Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
- CME/CE In-Person & Virtual Event
Beyond IOP: Integrating Ocular Surface Resilience into Glaucoma Management
March 13, 2026
Orlando, Florida
Programs
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry FeatureTreating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
- CME/CE In-Person & Virtual Event
Hidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
March 12, 2026
Orlando, Florida Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
CME/CEAdvancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
From Pixels to Practice: Advancing HCM Care With Multimodality Imaging
CME/CEFrom Pixels to Practice: Advancing HCM Care With Multimodality Imaging
Clinical Practice
From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
CME/CEFrom Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
Double-Class Refractory CLL in Community Practice: Current and Future Management
CME/CEDouble-Class Refractory CLL in Community Practice: Current and Future Management
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CENavigating Treatment Sequencing After Frontline Treatment Failure in CLL
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
MinuteCE®Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Doctors Lounge
"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
The Convergence"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
The Convergence"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Clinician's RoundtableArtificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple SclerosisMS Management: Strategies for Ensuring Equitable Access to Teleneurology
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
Messy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Rub Some Dirt In ItMessy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
CME
Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
MinuteCE®Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
MinuteCE®When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEOvercoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Industry Feature
Improving Outcomes and Reducing Delays in Orthopedic Surgery
Medical Industry FeatureImproving Outcomes and Reducing Delays in Orthopedic Surgery
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry FeatureLatest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Medical Industry FeatureTau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Early Referral in PMR Management and the Impact on Outcomes
Medical Industry FeatureEarly Referral in PMR Management and the Impact on Outcomes
Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Medical Industry FeatureTargeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach















































































































































